{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Acute+Schizophrenia", "query": { "condition": "Acute Schizophrenia" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 63, "total_pages": 7, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Acute+Schizophrenia&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-07-23T20:26:21.852Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01175135", "title": "An Inpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Treatment Of Acute Exacerbation Of Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "PF-02545920", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Risperidone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 259, "start_date": "2010-10", "completion_date": "2011-08", "has_results": true, "last_update_posted_date": "2018-05-22", "last_synced_at": "2026-07-23T20:26:21.852Z", "location_count": 38, "location_summary": "Little Rock, Arkansas • Anaheim, California • Escondido, California + 23 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Escondido", "state": "California" }, { "city": "Escondido", "state": "California" }, { "city": "Garden Grove", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01175135" }, { "nct_id": "NCT07363577", "title": "Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "LB-102 (50 mg tablet)", "type": "DRUG" }, { "name": "LB-102 (100 mg tablet)", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "LB Pharmaceuticals Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 456, "start_date": "2026-03-25", "completion_date": "2027-10", "has_results": false, "last_update_posted_date": "2026-05-06", "last_synced_at": "2026-07-23T20:26:21.852Z", "location_count": 13, "location_summary": "Bentonville, Arkansas • Little Rock, Arkansas • Culver City, California + 9 more", "locations": [ { "city": "Bentonville", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Culver City", "state": "California" }, { "city": "Garden Grove", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07363577" }, { "nct_id": "NCT04072354", "title": "A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "SEP-363856 50mg", "type": "DRUG" }, { "name": "SEP-363856 75mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "13 Years to 65 Years" }, "enrollment_count": 463, "start_date": "2019-09-17", "completion_date": "2023-09-12", "has_results": true, "last_update_posted_date": "2026-05-28", "last_synced_at": "2026-07-23T20:26:21.852Z", "location_count": 18, "location_summary": "Little Rock, Arkansas • Anaheim, California • Bellflower, California + 13 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Bellflower", "state": "California" }, { "city": "Lemon Grove", "state": "California" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04072354" }, { "nct_id": "NCT00694707", "title": "Safety and Efficacy of Cariprazine (RGH-188) in the Acute Exacerbation of Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Cariprazine", "type": "DRUG" }, { "name": "Risperidone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 732, "start_date": "2008-06-30", "completion_date": "2009-08-31", "has_results": true, "last_update_posted_date": "2019-06-12", "last_synced_at": "2026-07-23T20:26:21.852Z", "location_count": 18, "location_summary": "Costa Mesa, California • Long Beach, California • Oceanside, California + 14 more", "locations": [ { "city": "Costa Mesa", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Oceanside", "state": "California" }, { "city": "Paramount", "state": "California" }, { "city": "Riverside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00694707" }, { "nct_id": "NCT07116694", "title": "Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Bipolar I Disorder", "Bipolar II Disorder", "Schizophrenia", "Schizoaffective Disorder", "Schizophreniform Disorders", "Psychomotor Agitation" ], "interventions": [ { "name": "BXCL501 Sublingual Film", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "BioXcel Therapeutics Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 33, "start_date": "2025-06-19", "completion_date": "2025-10-07", "has_results": false, "last_update_posted_date": "2026-04-06", "last_synced_at": "2026-07-23T20:26:21.852Z", "location_count": 5, "location_summary": "Chino, California • Oceanside, California • Orange, California + 2 more", "locations": [ { "city": "Chino", "state": "California" }, { "city": "Oceanside", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Las Vegas", "state": "Nevada" } ], "official_url": "https://clinicaltrials.gov/study/NCT07116694" }, { "nct_id": "NCT03870880", "title": "Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Risperidone ISM 75 mg", "type": "DRUG" }, { "name": "Risperidone ISM 100 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rovi Pharmaceuticals Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 215, "start_date": "2017-08-25", "completion_date": "2020-01-08", "has_results": true, "last_update_posted_date": "2022-03-25", "last_synced_at": "2026-07-23T20:26:21.852Z", "location_count": 13, "location_summary": "Rogers, Arkansas • Garden Grove, California • Long Beach, California + 10 more", "locations": [ { "city": "Rogers", "state": "Arkansas" }, { "city": "Garden Grove", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Pico Rivera", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03870880" }, { "nct_id": "NCT00905307", "title": "Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "OPC-34712", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Aripiprazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 459, "start_date": "2009-07", "completion_date": "2010-11", "has_results": true, "last_update_posted_date": "2015-10-20", "last_synced_at": "2026-07-23T20:26:21.852Z", "location_count": 16, "location_summary": "Little Rock, Arkansas • Escondido, California • Garden Grove, California + 12 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Escondido", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Oceanside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00905307" }, { "nct_id": "NCT05723328", "title": "Music Therapy Advocacy Recording Intervention (MTAR) on Internalized Stigma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Mental Health Issues", "Bipolar Disorder", "Depressive", "Schizophrenia Spectrum and Other Psychotic Disorders", "Anxiety Disorder" ], "interventions": [ { "name": "Group Music Therapy Advocacy Recording Intervention (MTAR)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Hackensack Meridian Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 7, "start_date": "2023-04-25", "completion_date": "2023-04-26", "has_results": true, "last_update_posted_date": "2024-07-05", "last_synced_at": "2026-07-23T20:26:21.852Z", "location_count": 1, "location_summary": "Belle Mead, New Jersey", "locations": [ { "city": "Belle Mead", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05723328" }, { "nct_id": "NCT02335060", "title": "N-acetylcysteine Effects on Tetrahydrocannabinol", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Delta-9-THC", "type": "DRUG" }, { "name": "N-acetylcysteine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 5, "start_date": "2014-05-02", "completion_date": "2014-09-16", "has_results": false, "last_update_posted_date": "2022-01-31", "last_synced_at": "2026-07-23T20:26:21.852Z", "location_count": 1, "location_summary": "West Haven, Connecticut", "locations": [ { "city": "West Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT02335060" }, { "nct_id": "NCT06944847", "title": "Vaping and Smoking Project in People With Schizophrenia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Acute Abstinence From Cigarettes vs E-cigarettes (ENDS)" ], "interventions": [ { "name": "Acute (24-hour) abstinence", "type": "BEHAVIORAL" }, { "name": "Ad libitum smoking/vaping", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "State University of New York at Buffalo", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "21 Years to 50 Years" }, "enrollment_count": 64, "start_date": "2025-02-15", "completion_date": "2027-04-01", "has_results": false, "last_update_posted_date": "2026-03-09", "last_synced_at": "2026-07-23T20:26:21.852Z", "location_count": 1, "location_summary": "Buffalo, New York", "locations": [ { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06944847" } ] }